Pharmacogenetics of anti-seizure medications in Arab countries: a comprehensive review
Epilepsy, a prevalent neurological disorder, is characterized by recurring seizures due to atypical neural activity, impacting millions globally. Epileptic seizures are the sudden, involuntary jerking or trembling movements caused by abnormal neural activity and may lead to damage in the brain or ot...
Saved in:
Main Author: | Rania Magadmi |
---|---|
Format: | Article |
Language: | English |
Published: |
Taylor & Francis Group
2025-12-01
|
Series: | Future Science OA |
Subjects: | |
Online Access: | https://www.tandfonline.com/doi/10.1080/20565623.2025.2528490 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Pharmacogenetic markers of colorectal cancer treatment. New approaches for cytostatic drugs efficacy estimation
by: N. B. Zakharzhevskaya, et al.
Published: (2015-12-01) -
Adverse effects of antiseizure medications: a review of the impact of pharmacogenetics and drugs interactions in clinical practice
by: Michela De Bellis, et al.
Published: (2025-07-01) -
THE COMPARATIVE EFFICACY OF PERSONALIZING THERAPY WITH ANTICONVULSANTS AND ANTIPSYCHOTICS ON THE BASIS OF PHARMACOGENETIC TESTING
by: T. V. Dokukina, et al.
Published: (2016-08-01) -
Population biobank as a basis for determining spatial variation of clinically relevant pharmacogenetic biomarkers of cardiovascular diseases
by: V. Yu. Pylev, et al.
Published: (2022-12-01) -
OPPORTUNITIES TO OPTIMIZE ANTIEPILEPTIC THERAPY WITH USE OF PHARMACOGENETIC BIOMARKERS
by: T. V. Dokukina, et al.
Published: (2016-05-01)